Jonathan Leventhal, MD, is the director of the Onco-Dermatology Program at Smilow Cancer Hospital at Yale New Haven. He treats patients undergoing cancer treatment who experience itchy or painful rashes, as well as hair and nail changes that can result from either their disease or treatment, including chemotherapy, immunotherapy, radiation or stem cell transplantation. 鈥淥ne of the most rewarding aspects of my job is improving the quality of life for patients with cancer who are affected by adverse skin events,鈥 he says. Seeing an onco-dermatologist like Dr. Leventhal can make the difference between a patient being able to continue receiving a cancer treatment or having to be taken off it when the skin conditions become too severe. 鈥淚f left untreated, some skin, hair and nail conditions can become quite debilitating, even disfiguring and may negatively impact health and ability to perform day-to-day activities,鈥 says Dr. Leventhal. He helps to manage these skin problems so that patients with cancer can continue their treatments and enjoy a better quality of life. In addition to his role at Smilow, Dr. Leventhal, an associate professor of dermatology and associate director of the residency program at Yale School of Medicine, cares for patients with a wide range of skin conditions in Yale Medicine Dermatology鈥檚 New Haven and Branford locations. He performs routine skin cancer screening examinations and also treats general skin problems鈥攆rom acne to psoriasis to eczema. He is also the Associate Residency Program Director and is Principal Investigator of several clinical trials involving the management of cutaneous reactions to cancer therapy. "Every day I am excited to come to work, treating various skin conditions affecting my patients and helping patients with cancer continue their potentially life-saving treatments,鈥 says Dr. Leventhal. 鈥淪kin diseases can impact the way people see themselves and can affect how people feel, both physically and emotionally. My work is particularly gratifying when I can improve my patients' overall comfort, happiness and health.鈥 Education & Training: Resident- Yale University School of Medicine (2016) Intern- NYU Langone Hospital - Long Island (2013) MD- New York University (2012) Honors & Recognition: 2018 Medical Education Fellowship 2015 Hugh L. Dwyer Memorial Fund Award for Clinical Excellence
Cancer immunotherapy has revolutionized treatment of many forms of cancer by unleashing the immune system response against tumors. Immunotherapies that block checkpoint receptors like PD-1, proteins that limit the capacity of T cells to attack tumors, have become the choice for the treatment of numerous types of solid cancer.
23-Jun-2023 09:25:55 AM EDT